跳至主要内容
临床试验/NCT06529770
NCT06529770已完成不适用

Benefits of Ultrasound-Guided Percutaneous Neuromodulation on the Strength of CrossFit Athletes

Universidad de Zaragoza2 个研究点 分布在 1 个国家目标入组 39 人开始时间: 2024年9月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
39
试验地点
2
主要终点
Maximal Strength (1RM)

研究概览

简要总结

The origin of CrossFit (CF) dates back to 1995 when Greg Glassman opened the first facility dedicated to the sport he named CF in Santa Cruz, California. However, the dissemination and promotion of this sport began in 2000 with the creation of the CF brand alongside his wife Lauren Jenai. Today, the brand generates around 100 million euros annually and has a market valuation of approximately 4 billion euros. CF boasts 14,000 boxes in 155 countries, with over five million users. Spain ranks as the fifth country with the most CF centers.

CF training focuses on constantly varied functional movements, including gymnastics, weightlifting exercises, and cardiovascular activities (e.g., running or rowing). Variety is one of the main attractions for participants, as the workouts are short, intense, and diverse.

Within invasive physiotherapy, there is the technique of ultrasound-guided percutaneous neuromodulation (US-PNM), which enhances muscle function, muscle recruitment patterns, and motor control. This minimally invasive intervention involves the application of percutaneous electrical stimulation through an electrode similar to an acupuncture needle, placed in close proximity to the nerve or motor point of the target muscle under ultrasound guidance. Performing this technique under ultrasound guidance is recommended as it makes the procedure safer and more effective, allowing real-time visualization of needle positioning and technique application.

Most studies on US-PNM have focused on pain treatment in patients, but some studies have explored its benefits in healthy individuals. For instance, De-la-Cruz-Torre et al. demonstrated that applying this procedure to the sciatic nerve can increase hamstring flexibility; De-la-Cruz-Torres et al. also reported an increase in the performance of the flexor hallucis longus muscle in dancers; Álvarez-Prats et al. showed an improvement in quadriceps muscle strength after performing electrical stimulation on the femoral nerve; and Gallego-Sendarrubias et al. suggested an enhancement in performance skills in soccer players by applying the neuromodulation procedure to the femoral nerve before specific strength training.

Overall, the literature suggests that US-PNM intervention improves strength levels, but the results should be confirmed with future research due to sample size limitations and short-term evaluations. Additionally, there are currently no studies on the application of US-PNM in a sample of CF athletes. Therefore, the objective of this study is to analyze the effectiveness and duration of the effects of two US-PNM protocols applied to the axillary and suprascapular nerves on shoulder rotation strength in healthy CF athletes.

详细描述

The study aims to:

  • Analyze whether 3 sessions of ultrasound-guided percutaneous neuromodulation (US-PNM) are more effective than 1 session of US-PNM for shoulder rotation muscle strength in healthy CrossFit athletes.
  • Analyze whether the US-PNM intervention has a positive effect on the ability to perform a one-repetition maximum (1RM) in a functional CF movement, such as the "Shoulder Press," in healthy CrossFit athletes.

To achieve this, a randomized clinical trial is proposed with three study groups:

  • Control group: no intervention will be performed.
  • Experimental group 1 session US-PNM: will receive 1 session of US-PNM.
  • Experimental group 3 sessions US-PNM: will receive 3 sessions of US-PNM, with one week of separation between each session.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Be between 18 and 65 years old
  • •Have at least 1 year of experience in CrossFit training

排除标准

  • •Have not undergone any previous surgeries
  • •Have no pathology that causes any type of pain
  • •Have no physical impairment that would hinder dynamometry measurements (muscle injuries, joint instability, joint inflammation, etc.)
  • •Have no contraindications for the application of Ultrasound-Guided Percutaneous Neuromodulation (US-PNM) such as trypanophobia, pregnancy, epilepsy, or pacemakers.

研究组 & 干预措施

Control Group

No Intervention

The group receives no intervention

NMP-e 3 sessions

Experimental

The group receives 1 session of ultrasound-guided percutaneous neuromodulation. The session wil be received at day 1 of the study.

干预措施: NMP-e (Other)

NMP-e 1 session

Experimental

The group receives 3 sessions of ultrasound-guided percutaneous neuromodulation. The sessions wil be received at day 1, 7 and 14 of the study.

干预措施: NMP-e (Other)

结局指标

主要结局

Maximal Strength (1RM)

时间窗: Measurements will be taken only on the first and last days of the sessions (day 1 and day 21).

This will be measured using the "shoulder press" exercise.

次要结局

  • External Shoulder Rotator Muscle Strength. 90º abduction(Measurements will be conducted in all 4 sessions of the study (day 1, day 7, day 13, and day 21).)
  • Internal Shoulder Rotator Muscle Strength. 0º abduction(Measurements will be conducted in all 4 sessions of the study (day 1, day 7, day 13, and day 21).)
  • Internal Shoulder Rotator Muscle Strength. 90º abduction(Measurements will be conducted in all 4 sessions of the study (day 1, day 7, day 13, and day 21).)
  • External Shoulder Rotator Muscle Strength. 0º abduction(Measurements will be conducted in all 4 sessions of the study (day 1, day 7, day 13, and day 21).)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr. Pablo Herrero Gallego

Physiotherapist

Universidad de Zaragoza

研究点 (2)

Loading locations...

相似试验